Anavex Life Sciences (AVXL) Net Cash Flow Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - | 355.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 355.63% |
| Sep 30, 2025 | 121.51% |
| Jun 30, 2025 | -2,218.57% |
| Mar 31, 2025 | -14.27% |
| Dec 31, 2024 | -57.21% |
| Sep 30, 2024 | -73.19% |
| Jun 30, 2024 | -146.67% |
| Mar 31, 2024 | -144.48% |
| Dec 31, 2023 | -31.12% |
| Sep 30, 2023 | 6.15% |
| Jun 30, 2023 | 1,042.71% |
| Mar 31, 2023 | 348.27% |
| Dec 31, 2022 | -475.83% |
| Sep 30, 2022 | 25.87% |
| Jun 30, 2022 | -100.18% |
| Mar 31, 2022 | -92.29% |
| Dec 31, 2021 | -105.31% |
| Sep 30, 2021 | -434.51% |
| Jun 30, 2021 | 7,636.27% |
| Mar 31, 2021 | 3,283.30% |
| Dec 31, 2020 | 243.43% |
| Sep 30, 2020 | 74.05% |
| Jun 30, 2020 | -41.05% |
| Mar 31, 2020 | 28.79% |
| Dec 31, 2019 | 338.00% |
| Sep 30, 2019 | 132.32% |
| Jun 30, 2019 | 947.53% |
| Mar 31, 2019 | 47.44% |
| Dec 31, 2018 | -464.15% |
| Sep 30, 2018 | -209.45% |
| Jun 30, 2018 | -88.14% |
| Mar 31, 2018 | -209.22% |
| Dec 31, 2017 | -94.92% |
| Sep 30, 2017 | 589.95% |
| Jun 30, 2017 | 164.84% |
| Mar 31, 2017 | 215.11% |
| Dec 31, 2016 | 932.98% |
| Sep 30, 2016 | -107.37% |
| Jun 30, 2016 | -234.72% |
| Mar 31, 2016 | -183.84% |
| Dec 31, 2015 | -411.20% |
| Sep 30, 2015 | 898.83% |
| Jun 30, 2015 | 262.81% |
| Mar 31, 2015 | -107.37% |
| Dec 31, 2014 | -12.87% |
| Sep 30, 2014 | -367.17% |
| Jun 30, 2014 | -87,654.15% |
| Mar 31, 2014 | 11,572.13% |
| Dec 31, 2013 | -464.11% |
| Sep 30, 2013 | 5,126.04% |
| Jun 30, 2013 | 100.72% |
| Mar 31, 2013 | -146.77% |
| Dec 31, 2012 | 154.47% |
| Sep 30, 2012 | 99.37% |
| Jun 30, 2012 | -113.16% |
| Mar 31, 2012 | 140.36% |
| Dec 31, 2011 | -178.95% |
| Sep 30, 2011 | 8.61% |